Cargando…
Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
OBJECTIVE: To examine the utility of the new Movement Disorder Society (MDS) diagnostic criteria in a large cohort of Parkinson's disease (PD) patients. METHODS: Recently diagnosed (<3.5 years) PD cases fulfilling United Kingdom (UK) brain bank criteria in Tracking Parkinson's, a UK mul...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570813/ https://www.ncbi.nlm.nih.gov/pubmed/28431829 http://dx.doi.org/10.1016/j.parkreldis.2017.04.006 |
_version_ | 1783259224516591616 |
---|---|
author | Malek, Naveed Lawton, Michael A. Grosset, Katherine A. Bajaj, Nin Barker, Roger A. Ben-Shlomo, Yoav Burn, David J. Foltynie, Tom Hardy, John Morris, Huw R. Williams, Nigel M. Wood, Nicholas Grosset, Donald G. |
author_facet | Malek, Naveed Lawton, Michael A. Grosset, Katherine A. Bajaj, Nin Barker, Roger A. Ben-Shlomo, Yoav Burn, David J. Foltynie, Tom Hardy, John Morris, Huw R. Williams, Nigel M. Wood, Nicholas Grosset, Donald G. |
author_sort | Malek, Naveed |
collection | PubMed |
description | OBJECTIVE: To examine the utility of the new Movement Disorder Society (MDS) diagnostic criteria in a large cohort of Parkinson's disease (PD) patients. METHODS: Recently diagnosed (<3.5 years) PD cases fulfilling United Kingdom (UK) brain bank criteria in Tracking Parkinson's, a UK multicenter prospective natural history study were assessed by retrospective application of the MDS criteria. RESULTS: In 2000 cases, 1835 (91.7%) met MDS criteria for PD, either clinically established (n = 1261, 63.1%) or clinically probable (n = 574, 28.7%), leaving 165 (8.3%) not fulfilling criteria. Clinically established cases were significantly more likely to have limb rest tremor (89.3%), a good l-dopa response (79.5%), and olfactory loss (71.1%), than clinically probable cases (60.6%, 44.4%, and 34.5% respectively), but differences between probable PD and ‘not PD’ cases were less evident. In cases not fulfilling criteria, the mean MDS UPDRS3 score (25.1, SD 13.2) was significantly higher than in probable PD (22.3, SD 12.7, p = 0.016) but not established PD (22.9, SD 12.0, p = 0.066). The l-dopa equivalent daily dose of 341 mg (SD 261) in non-PD cases was significantly higher than in probable PD (250 mg, SD 214, p < 0.001) and established PD (308 mg, SD 199, p = 0.025). After 30 months' follow-up, 89.5% of clinically established cases at baseline remained as PD (established/probable), and 86.9% of those categorized as clinically probable at baseline remained as PD (established/probable). Cases not fulfilling PD criteria had more severe parkinsonism, in particular relating to postural instability, gait problems, and cognitive impairment. CONCLUSION: Over 90% of cases clinically diagnosed as early PD fulfilled the MDS criteria for PD. Those not fulfilling criteria may have an atypical parkinsonian disorder or secondary parkinsonism that is not correctly identified by the UK Brain Bank criteria, but possibly by the new criteria. |
format | Online Article Text |
id | pubmed-5570813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55708132017-08-30 Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases Malek, Naveed Lawton, Michael A. Grosset, Katherine A. Bajaj, Nin Barker, Roger A. Ben-Shlomo, Yoav Burn, David J. Foltynie, Tom Hardy, John Morris, Huw R. Williams, Nigel M. Wood, Nicholas Grosset, Donald G. Parkinsonism Relat Disord Article OBJECTIVE: To examine the utility of the new Movement Disorder Society (MDS) diagnostic criteria in a large cohort of Parkinson's disease (PD) patients. METHODS: Recently diagnosed (<3.5 years) PD cases fulfilling United Kingdom (UK) brain bank criteria in Tracking Parkinson's, a UK multicenter prospective natural history study were assessed by retrospective application of the MDS criteria. RESULTS: In 2000 cases, 1835 (91.7%) met MDS criteria for PD, either clinically established (n = 1261, 63.1%) or clinically probable (n = 574, 28.7%), leaving 165 (8.3%) not fulfilling criteria. Clinically established cases were significantly more likely to have limb rest tremor (89.3%), a good l-dopa response (79.5%), and olfactory loss (71.1%), than clinically probable cases (60.6%, 44.4%, and 34.5% respectively), but differences between probable PD and ‘not PD’ cases were less evident. In cases not fulfilling criteria, the mean MDS UPDRS3 score (25.1, SD 13.2) was significantly higher than in probable PD (22.3, SD 12.7, p = 0.016) but not established PD (22.9, SD 12.0, p = 0.066). The l-dopa equivalent daily dose of 341 mg (SD 261) in non-PD cases was significantly higher than in probable PD (250 mg, SD 214, p < 0.001) and established PD (308 mg, SD 199, p = 0.025). After 30 months' follow-up, 89.5% of clinically established cases at baseline remained as PD (established/probable), and 86.9% of those categorized as clinically probable at baseline remained as PD (established/probable). Cases not fulfilling PD criteria had more severe parkinsonism, in particular relating to postural instability, gait problems, and cognitive impairment. CONCLUSION: Over 90% of cases clinically diagnosed as early PD fulfilled the MDS criteria for PD. Those not fulfilling criteria may have an atypical parkinsonian disorder or secondary parkinsonism that is not correctly identified by the UK Brain Bank criteria, but possibly by the new criteria. Elsevier Science 2017-07 /pmc/articles/PMC5570813/ /pubmed/28431829 http://dx.doi.org/10.1016/j.parkreldis.2017.04.006 Text en Crown Copyright © 2017 Published by Elsevier Ltd. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Malek, Naveed Lawton, Michael A. Grosset, Katherine A. Bajaj, Nin Barker, Roger A. Ben-Shlomo, Yoav Burn, David J. Foltynie, Tom Hardy, John Morris, Huw R. Williams, Nigel M. Wood, Nicholas Grosset, Donald G. Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases |
title | Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases |
title_full | Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases |
title_fullStr | Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases |
title_full_unstemmed | Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases |
title_short | Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases |
title_sort | utility of the new movement disorder society clinical diagnostic criteria for parkinson's disease applied retrospectively in a large cohort study of recent onset cases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570813/ https://www.ncbi.nlm.nih.gov/pubmed/28431829 http://dx.doi.org/10.1016/j.parkreldis.2017.04.006 |
work_keys_str_mv | AT maleknaveed utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT lawtonmichaela utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT grossetkatherinea utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT bajajnin utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT barkerrogera utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT benshlomoyoav utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT burndavidj utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT foltynietom utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT hardyjohn utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT morrishuwr utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT williamsnigelm utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT woodnicholas utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT grossetdonaldg utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases AT utilityofthenewmovementdisordersocietyclinicaldiagnosticcriteriaforparkinsonsdiseaseappliedretrospectivelyinalargecohortstudyofrecentonsetcases |